Drug-Target Information
Drug Name Target Name Drug Type Target Type Source Drug MeSHID Interaction Score Drug Status Target Action
pemetrexed bifunctional purine biosynthesis protein purh small molecule NA drugbank , DGIDB Malignant mesothelioma[MeSHID:C562839]
Disease[MeSHID:D004194]
Pleura[MeSHID:D010994]
Operative Surgical Procedures[MeSHID:D013514]
Non-Small Cell Lung Carcinoma[MeSHID:D002289]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 11.37 approved,investigational inhibitor
pemetrexed dihydrofolate reductase small molecule NA drugbank , DGIDB Malignant mesothelioma[MeSHID:C562839]
Disease[MeSHID:D004194]
Pleura[MeSHID:D010994]
Operative Surgical Procedures[MeSHID:D013514]
Non-Small Cell Lung Carcinoma[MeSHID:D002289]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 5.4 approved,investigational inhibitor
pemetrexed trifunctional purine biosynthetic protein adenosine-3 small molecule NA drugbank , DGIDB Malignant mesothelioma[MeSHID:C562839]
Disease[MeSHID:D004194]
Pleura[MeSHID:D010994]
Operative Surgical Procedures[MeSHID:D013514]
Non-Small Cell Lung Carcinoma[MeSHID:D002289]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 18.19 approved,investigational inhibitor
pemetrexed thymidylate synthase small molecule NA drugbank , DGIDB Malignant mesothelioma[MeSHID:C562839]
Disease[MeSHID:D004194]
Pleura[MeSHID:D010994]
Operative Surgical Procedures[MeSHID:D013514]
Non-Small Cell Lung Carcinoma[MeSHID:D002289]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 2.46 approved,investigational inhibitor
click here to return to the previous page